ACTR2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.122820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.373900E-02
Normal-vs-Stage2
1.292630E-01
Normal-vs-Stage3
7.619800E-02
Normal-vs-Stage4
9.481400E-01
Stage1-vs-Stage2
3.255000E-01
Stage1-vs-Stage3
6.513600E-01
Stage1-vs-Stage4
7.051500E-02
Stage2-vs-Stage3
2.222600E-01
Stage2-vs-Stage4
1.050800E-01
Stage3-vs-Stage4
8.259800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.696400E-02
Normal-vs-AfricanAmerican
5.288600E-01
Normal-vs-Asian
3.770200E-02
Caucasian-vs-AfricanAmerican
3.411400E-01
Caucasian-vs-Asian
2.926400E-01
AfricanAmerican-vs-Asian
1.635950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.198400E-01
Normal-vs-Female
1.198050E-01
Male-vs-Female
6.135400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.622600E-01
Normal-vs-Age(41-60Yrs)
2.434200E-01
Normal-vs-Age(61-80Yrs)
8.994200E-02
Normal-vs-Age(81-100Yrs)
4.735500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.606000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.949600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.608200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.904400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.812200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.704000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.403700E-02
Normal-vs-Daily Drinker
3.925600E-02
Normal-vs-Weekly Drinker
7.215900E-02
Normal-vs-Occasional Drinker
4.080000E-01
Normal-vs-Social Drinker
2.744400E-01
Non Drinker-vs-Daily Drinker
3.758600E-01
Non Drinker-vs-Weekly Drinker
7.686800E-01
Non Drinker-vs-Occasional Drinker
1.642400E-01
Non Drinker-vs-Social Drinker
4.152400E-01
Daily Drinker-vs-Weekly Drinker
6.648800E-01
Daily Drinker-vs-Occasional Drinker
6.969900E-02
Daily Drinker-vs-Social Drinker
1.854650E-01
Weekly Drinker-vs-Occasional Drinker
2.106800E-01
Weekly Drinker-vs-Social Drinker
4.046800E-01
Occasional Drinker-vs-Social Drinker
6.780800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.789000E-01
Normal-vs-Grade 2
2.737800E-02
Normal-vs-Grade 3
4.270300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.384030E-01
Grade 1-vs-Grade 3
6.565800E-02
Grade 1-vs-Grade 4
2.789000E-01
Grade 2-vs-Grade 3
5.084400E-01
Grade 2-vs-Grade 4
2.737800E-02
Grade 3-vs-Grade 4
4.270300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.332190E-01
Normal-vs-NonDiabetic
5.568000E-02
Diabetic-vs-NonDiabetic
8.261800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.734180E-01
Normal-vs-NoPancreatitis
1.001630E-01
Pancreatitis-vs-NoPancreatitis
2.969700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.185030E-01
Normal-vs-N1
1.308770E-01
N0-vs-N1
3.892400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.434600E-01
Normal-vs-TP53-NonMutant
7.398400E-02
TP53-Mutant-vs-TP53-NonMutant
7.160300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
